2. Spółki
  3. Raporty Spółek ESPI/EBI

Raporty Spółek ESPI/EBI

Notification for dividend payment SOPHARMA AD (BG11SOSOBT18)

30-10-2026 12:37:08 | ESPI | 301/2026
oUNI-EN: Notification for dividend payment

 PAP
Data: 2026-10-30
Firma: SOPHARMA AD
oSpis tresci:
1. REPORT
2. ESAP METADATE
3. INFORMATION ABOUT THE ENTITY
4. SIGNATURE OF PERSONS REPRESENTING THE COMPANY

oSpis zalacznikow:
Znaleziono 1 załącznik
  • SFA_dividend_30102026_EN.pdf
    		•  Arkusz: REPORT

    Nazwa arkusza: REPORT


    POLISH FINANCIAL SUPERVISION AUTHORITY
    UNI - EN REPORT No 301 / 2026
    Date of issue: 2026-10-30
    Short name of the issuer
    SOPHARMA AD
    Subject
    Notification for dividend payment
    Official market - legal basis
    Art. 56 ust. 1 pkt 2 Ustawy o ofercie - informacje bieżące i okresowe
    Unofficial market - legal basis
    Contents of the report:
    In accordance with the requirements of art. 115c, para. 4 of LPOS "Sopharma" AD _SFA: Bulgarian Stock Exchange, SPH: Warsaw Stock Exchange_ notifies all shareholders of the Company about the decision of the AGM of "Sopharma" AD that took place on October 30, 2026 regarding the type and amount of the voted dividend for 2026, the terms and conditions for its payment:
    The General Meeting of Shareholders voted against the Board of Directors' proposal and adopted a proposal made by a shareholder to distribute a gross dividend of 0.068 euros _6.8 euro cents_ per share.
    The right to receive dividends is granted to persons registered in the the central securities register as shareholders on the 14th day after the day of the General Meeting at which the annual financial report for 2026 was adopted and a decision was made to pay a dividend, namely November 13, 2026 _dividend record date_; respectively, ex-dividend date - November 12, 2026; starting date for dividend payment - November 27, 2026.
    In accordance with the Regulations of "Central Depository" AD, the dividend will be paid as follows: for shareholders with client accounts with investment intermediaries - through the respective investment intermediary; for shareholders without accounts with investment intermediaries - through the branches of "Eurobank Bulgaria" AD _Post Bank_ in the country.
    We draw the attention of all foreign shareholders who wish to provide original documents for avoiding double taxation to do so no later than November 10, 2026 at the address: Sofia 1756, 5 "Lachezar Stanchev" Str., Tower A, floor 11, at the attention of the Investor Relations Department _contacts for additional information ir@sopharma.bg / +359 2 8134 319_.
    Annexes
    File Description
    SFA_dividend_30102026_EN.pdf Notification for dividend payment

    Nazwa arkusza: ESAP METADATE


    Legal framework Type of information
    TRANSD Inside information
    RegulatoryData
    Collection Body PLKNF
    Unique data record identifier
    Type of submission New _to be used for new information_
    Voluntary information flag
    Date or period covered [Date or beginning of the period to which the information relates] 2027-01-01
    Date or period covered [Date or end of the period to which the information relates] 2027-06-30
    Personal data flag
    Macierzyste państwo członkowskie, w stosownych przypadkach PL
    DocumentReference
    Język, w którym przekazano informacje Oryginał _ORIG_ czy tłumaczenie _TRAN_ Numer referencyjny pliku danych
    PL ORIG
    SubmittingEntity
    Submitting entity LEI or Submitting entity name - natural person
    RelatedEntity/LegalPerson
    Entity LEI Size of the entity Industry sector_s_
    097900BGGW0000048796 Large undertaking _acc. NACE_: C

    Nazwa arkusza: INFORMATION ABOUT THE ENTITY


    SOPHARMA AD
    _fullname of the issuer_
    SOPHARMA AD Farmaceutyczny _far_
    _short name of the issuer_ _sector according to clasification
    of the WSE in Warsow_
    1220 Sofia
    _post code_ _city_
    IlienskoShosse 16
    _street_ _number_
    +359 2 813 42 00 +359 2 936 02 86
    _phone number_ _fax_
    _e-mail_ _web site_
    nd
    _NIP_ _REGON_

    Nazwa arkusza: SIGNATURE OF PERSONS REPRESENTING THE COMPANY


    SIGNATURE OF PERSONS REPRESENTING THE COMPANY
    Date Name Position / Function Signature
    2026-10-30 Ognian Ivanov Donev Executive Director


    Identyfikator raportu jjvuszwyf1
    Nazwa raportu UNI-EN
    Symbol raportu UNI-EN
    Nazwa emitenta SOPHARMA AD
    Symbol Emitenta SOPHARMA AD
    Tytul Notification for dividend payment
    Sektor Farmaceutyczny (far)
    Kod 1220
    Miasto Sofia
    Ulica IlienskoShosse
    Nr 16
    Tel. +359 2 813 42 00
    Fax +359 2 936 02 86
    e-mail
    NIP nd
    REGON
    Data sporzadzenia 2026-10-30
    Rok biezacy 2026
    Numer 301
    adres www
    Serwis Ekonomiczny Polskiej Agencji Prasowej SA 2026 Copyright PAP SA - Wszelkie prawa zastrzezone.